Differences in Compositions of Gut Bacterial Populations and Bacteriophages in 5-11 Year-Olds Born Preterm Compared

Thilini N Jayasinghe1, Tommi Vatanen1,2, Valentina Chiavaroli1

  • 1Liggins Institute, University of Auckland, Auckland, New Zealand.

Insights

Gut microbiome differences in very preterm infants persist into childhood, affecting metabolites but not bacterial composition. These early-life changes may influence long-term health responses.

Area of Science:

  • Microbiome research
  • Pediatric health
  • Gastroenterology

Background:

  • Preterm infants undergo significant early life events impacting gut microbiome development.
  • Previous studies indicate altered gut microbial composition in preterm infants during early life.

Purpose of the Study:

  • To investigate if gut microbial composition and metabolite differences in very preterm children persist into mid-childhood.
  • To analyze the gut microbiome structure and function in prepubertal children born very preterm versus at term.

Main Methods:

  • Multi-omics analysis including 16S rRNA sequencing, shotgun metagenomics, and SPME-GCMS on fecal samples.
  • Cross-sectional study of healthy children aged 5-11 years, born very preterm (≤32 weeks gestation) or at term.
  • Collected data on demographics, birth characteristics, feeding, birth mode, and anthropometrics.

Main Results:

  • Children born very preterm were younger, shorter, and leaner than the term group.
  • Very preterm children exhibited higher fecal calprotectin, decreased fecal phage richness, lower plasma arginine, and altered fecal volatile profiles.
  • No significant differences were observed in the overall bacterial microbiome composition between the groups.

Conclusions:

  • Gut microbiome alterations, particularly in metabolites and phage richness, persist from very preterm birth into mid-childhood.
  • These persistent changes may have originated in early infancy and could affect the children's ability to adapt to environmental shifts.
  • Further research is needed to understand the long-term health implications of these persistent microbiome differences.

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
155
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
655
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
117
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
180